Added to YB: 2026-08-10
Pitch date: 2026-08-06
MRK.DE [neutral]
Merck KGaA
-1.07%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
Market Cap
EUR 63.1B
Pitch Price
EUR 145.20
Price Target
N/A
Dividend
1.52%
EV/EBITDA
12.96
P/E
26.63
EV/Sales
3.43
Sector
Pharmaceuticals
Category
growth
Merck (MRK Germany): Broad-based strength drives guidance upgrade
MRK.DE (earnings): Q2 beat on rev, EPS, EBITDA; raised FY guidance across all 3 divisions. Organic rev +4.1%. Life Science Process Solutions double-digit growth (inventory correction ending); Electronics strong on semi/AI materials; Healthcare resilient, Mavenclad decline milder than feared. Guidance up despite no US Mavenclad/Pergoveris from Aug. Bio-Techne deal broadens platform. Valuation reasonable vs peers.
Read full article (2 min)